Updated:
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001567514, and its reported...
Overview
Intra-Cellular Therapies, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001567514, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-21, it reported annual revenue of USD 680,852,000; net income of USD -74,676,000; total assets of USD 1,366,912,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Intra-Cellular Therapies, Inc.
- Former names in filing history
- Intra-Cellular Therapies, Inc. (2013-09-05 to 2025-06-05); Oneida Resources Corp. (2013-02-08 to 2013-08-29)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Bedminster, NJ, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001567514
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2024USD | $680.9M | -$74.7M | $1.4B | $306.9M | -$73.2M | |
| FY2023USD | $464.4M | -$139.7M | $728.3M | $147.8M | -$124.2M | |
| FY2022USD | $250.3M | -$256.3M | $754.8M | $148.6M | -$270.2M | |
| FY2021USD | $83.8M | -$284.1M | $489.9M | $92.4M | -$259.5M |
FY2021. Revenue, Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Intra-Cellular Therapies, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.